NCT06545851

Brief Summary

Long-term oxygen therapy is a fundamental treatment modality for patients with chronic hypoxaemic lung disease. Typically, oxygen is administered at a constant flow rate. However, due to fluctuating activity levels, patients' oxygenation status can vary, potentially leading to oxygen desaturation and increased dyspnoea. Emerging evidence suggests that automatic oxygen titration - a method of adjusting oxygen flow in response to current oxygen saturation - may have acute advantages over constant oxygen flow. The primary objective of this study is to investigate the effect of automatic oxygen titration compared to prescribed constant oxygen flow rates on patients' perceived dyspnoea during exercise endurance training.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

August 14, 2023

Completed
12 months until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

August 8, 2023

Last Update Submit

August 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dyspnea

    Change of dyspnea sensation rated by modified Borg scale (0 to 10) taken before and after exercise training

    Day 1 to 5 and 6 to 10

Secondary Outcomes (9)

  • Change of oxygen saturation (SpO2) during exercise training

    Day 1 to 5 and 6 to 10

  • Change of transcutaneous partial CO2 pressure (TcPCO2) during exercise training

    Day 1 to 5 and 6 to 10

  • Change of heart rate during exercise training

    Day 1 to 5 and 6 to 10

  • Change of capillary partial pressure of CO2 (pCO2) during exercise training

    Day 1 to 5 and 6 to 10

  • Change of capillary partial pressure of O2 (pO2) during exercise training

    Day 1 to 5 and 6 to 10

  • +4 more secondary outcomes

Study Arms (2)

Excercise Training Order A and B

EXPERIMENTAL

The first series of five exercise trainings (A) involves supplemental oxygen therapy, with automatically titrated oxygen flow rates to maintain an oxygen saturation of 90-94% (A). The second series of five exercise trainings employs supplemental oxygen therapy with constant flow rates (B), as prescribed.

Other: Oxygen therapy - constant oxygen flowOther: Oxygen therapy - automatic titrating oxygen flow

Excercise Training Order B and A

EXPERIMENTAL

The first series of five exercise trainings employs supplemental oxygen therapy with constant flow rates (B), as prescribed.The second five series of five exercise trainings involves supplemental oxygen therapy, with automatically titrated oxygen flow rates to maintain an oxygen saturation of 90-94% (A).

Other: Oxygen therapy - constant oxygen flowOther: Oxygen therapy - automatic titrating oxygen flow

Interventions

During five exercise training sessions, oxygen therapy is delivered via prescribed constant oxygen flow

Excercise Training Order A and BExcercise Training Order B and A

During five exercise sessions, oxygen therapy is delivered via an automatically titrated oxygen flow rate to maintain an SpO2 target of 90-94%.

Excercise Training Order A and BExcercise Training Order B and A

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic lung disease
  • Hypoxemia (pO2\< 55mmHg) under room air conditions (rest or during exercise) or SpO2\<88% during exercise
  • established Long-term oxygen therapy or given indication for a Long-term oxygen therapy/ supplemental oxygen therapy for exercise
  • Age: 18 to 80 years
  • Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)
  • Written informed consent

You may not qualify if:

  • \- Acute exacerbation of underlying pulmonary disease requiring cessation of exercise training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinikum Berchtesgadener Land, Schön Kliniken

Schönau am Königssee, Bavaria, 83471, Germany

RECRUITING

Related Publications (3)

  • Kofod LM, Westerdahl E, Kristensen MT, Brocki BC, Ringbaek T, Hansen EF. Effect of Automated Oxygen Titration during Walking on Dyspnea and Endurance in Chronic Hypoxemic Patients with COPD: A Randomized Crossover Trial. J Clin Med. 2021 Oct 20;10(21):4820. doi: 10.3390/jcm10214820.

    PMID: 34768338BACKGROUND
  • Schneeberger T, Jarosch I, Leitl D, Gloeckl R, Hitzl W, Dennis CJ, Geyer T, Criee CP, Koczulla AR, Kenn K. Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial. Thorax. 2023 Apr;78(4):326-334. doi: 10.1136/thoraxjnl-2020-216509. Epub 2021 Oct 16.

    PMID: 34656996BACKGROUND
  • Vivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pepin JL. Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial. Thorax. 2019 Mar;74(3):298-301. doi: 10.1136/thoraxjnl-2018-211967. Epub 2018 Aug 30.

    PMID: 30166425BACKGROUND

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andreas Rembert Koczulla, Prof. Dr.

    Philipps University Marburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andreas Rembert Koczulla, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The participant and investigator is blinded to the type of oxygen supply (constant flow or automatic titrating flow).
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 8, 2023

First Posted

August 9, 2024

Study Start

August 14, 2023

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

August 13, 2024

Record last verified: 2024-08

Locations